Prevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings

被引：14
|
作者：
Lee, Andie S. [1 ,2 ]
Huttner, Benedikt [3 ,4 ]
Harbarth, Stephan [3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Infect Dis, Missenden Rd, Sydney, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Dept Microbiol, Missenden Rd, Sydney, NSW 2050, Australia
[3] Univ Hosp Geneva, Infect Control Programme, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
[4] Univ Hosp Geneva, Div Infect Dis, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2016年 / 30卷 / 04期
关键词：
Methicillin-resistant Staphylococcus aureus; MRSA; Epidemiology; Infection prevention; Infection control; Active surveillance cultures; Screening; Decolonization; SURGICAL-SITE INFECTIONS; INTERRUPTED TIME-SERIES; IMPROVED HAND HYGIENE; ENVIRONMENTAL CLEANING INTERVENTION; CLOSTRIDIUM-DIFFICILE INFECTION; HOSPITAL-ACQUIRED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE; ANTIBIOTIC STEWARDSHIP; SURVEILLANCE CULTURES;
D O I：
10.1016/j.idc.2016.07.006
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of health care associated infections worldwide. Controversies with regard to the effectiveness of various MRSA control strategies have contributed to varying approaches to the control of this pathogen in different settings. However, new evidence from large-scale studies has emerged, particularly with regards to MRSA screening and decolonization strategies, which will inform future control practices. The implementation as well as outcomes of control measures in the real world is not only influenced by scientific evidence but also depends on economic, administrative, governmental, and political influences.
引用
收藏
页码：931 / +
页数：23
相关论文
共 50 条
  • [31] Methicillin-resistant Staphylococcus aureus
    Andie S. Lee
    Hermínia de Lencastre
    Javier Garau
    Jan Kluytmans
    Surbhi Malhotra-Kumar
    Andreas Peschel
    Stephan Harbarth
    Nature Reviews Disease Primers, 4
  • [32] Methicillin-Resistant Staphylococcus Aureus
    Al-Quorain, Abdulaziz
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2016, 4 (01): : 1 - 1
  • [33] Methicillin-resistant Staphylococcus aureus
    Tenover, FC
    Pearson, ML
    EMERGING INFECTIOUS DISEASES, 2004, 10 (11) : 2052 - 2053
  • [34] Do guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus make a difference?
    Humphreys, H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 39 - 43
  • [35] Prevention and control of methicillin-resistant Staphylococcus aureus nosocomial infection in Barcelona (Spain)
    Trilla, A
    Marco, F
    Moreno, AV
    Prat, A
    Vila, J
    Bayas, JM
    deAnta, MTJ
    CHEMOTHERAPY, 1996, 42 : 53 - 59
  • [36] Methicillin-resistant Staphylococcus aureus in a tertiary care hospital
    Navaneeth, BV
    Sridaran, D
    Suganthi, N
    Belwadi, MRS
    TROPICAL DOCTOR, 2002, 32 (03) : 182 - 183
  • [37] Methicillin-resistant Staphylococcus aureus in intensive care units
    Kochhar, S
    French, S
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2005, 98 (02) : 86 - 86
  • [38] Methicillin-resistant Staphylococcus aureus on the intensive care unit
    Hardy, KJ
    Hawkey, PM
    Oppenheim, BA
    Gao, F
    BRITISH JOURNAL OF ANAESTHESIA, 2003, 90 (04) : 554P - 554P
  • [39] Methicillin-resistant Staphylococcus aureus infections in acute rhinosinusitis
    Huang, WH
    Hung, PK
    LARYNGOSCOPE, 2006, 116 (02): : 288 - 291
  • [40] Methicillin-resistant Staphylococcus aureus infection in palliative care
    Prentice, W
    Dunlop, R
    Armes, PJ
    Cunningham, DE
    Lucas, C
    Todd, J
    PALLIATIVE MEDICINE, 1998, 12 (06) : 443 - 449
12345